# Vaccines Against Salmonella Typhi

> **NCT02324751** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 112 (actual)

## Conditions studied

- Typhoid Fever
- Enteric Fever

## Interventions

- **BIOLOGICAL:** Vi-TCV
- **BIOLOGICAL:** Vi-PS Vaccine
- **BIOLOGICAL:** Control (Men ACWY)

## Key facts

- **NCT ID:** NCT02324751
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-12-02
- **Final completion:** 2022-06-27
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324751, "Vaccines Against Salmonella Typhi". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02324751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*